Effects of Rituximab on Atherosclerotic Biomarkers in Kidney Transplant Recipients.

Alıyeva, Numuna; Demır, E; Akgul, Sebahat; Temurhan, Sonay; Ucar, Ar; Dırım, Ahmet; Bayraktar, Adem; Catıkkas, Nezahat; Erol, Ayşe; Calıskan, Y; Yazıcı, Halil; Yelken, B; Savran, Fatma; Turkmen, Aydın

doi:10.1016/j.transproceed.2019.01.106

Effects of Rituximab on Atherosclerotic Biomarkers in Kidney Transplant Recipients.

Atıf İçin Kopyala

Alıyeva N., Demır E., Akgul S., Temurhan S., Ucar A., Dırım A. B., ...Daha Fazla

Transplantation proceedings, cilt.51, sa.4, ss.1118-1120, 2019 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 51 Sayı: 4
Basım Tarihi: 2019
Doi Numarası: 10.1016/j.transproceed.2019.01.106
Dergi Adı: Transplantation proceedings
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1118-1120
İstanbul Üniversitesi Adresli: Evet

Özet

Introduction. Cardiovascular disease is the leading cause of mortality in kidney transplant recipients. Rituximab is widely used in kidney transplantation for a variety of situations, and rituximab may inhibit some cytokines and antibodies that may play an active role in the atherosclerotic process. The aim of the study was to evaluate the efficacy of rituximab on atherosclerosis biomarkers in kidney transplant recipients.